Related Experiment Video
Updated: Aug 4, 2026

08:45
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Management of Infections Caused by Candida glabrata
1Department of Internal Medicine, Wayne State University School of Medicine and Harper Hospital, 4 Brush, Room 4811, 3990 John R, Detroit, MI 48201, USA. jsobel@intmed.wayne.edu
Current Infectious Disease Reports
|November 30, 2000
Summary
Candida glabrata infections are increasing due to azole resistance, posing a significant challenge. Understanding its resistance mechanisms is crucial for developing new antifungal treatments.
Area of Science:
- Mycology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- * Rising incidence of *Candida glabrata* infections, becoming increasingly common.
- * Widespread and indiscriminate use of azole antifungals, particularly fluconazole, is a primary driver.
- * *C. glabrata* exhibits resistance to existing azoles, including novel agents, and requires higher amphotericin B doses.
Purpose of the Study:
- * To investigate the growing problem of *Candida glabrata* infections.
- * To explore the limited knowledge regarding its epidemiology and virulence factors.
- * To highlight the importance of studying resistance mechanisms for developing new antifungal therapies.
Main Methods:
- * Review of current literature on *Candida glabrata* epidemiology and azole resistance.
- * Analysis of clinical trends and treatment challenges associated with this pathogen.
- * Focus on understanding the genetic and biochemical basis of antifungal resistance.
Main Results:
- * *C. glabrata* is a significant cause of opportunistic fungal infections.
- * Azole resistance in *C. glabrata* is a major clinical concern, limiting treatment options.
- * Amphotericin B efficacy is reduced, necessitating higher dosages.
Conclusions:
- * *Candida glabrata* represents a critical challenge in antifungal therapy due to widespread resistance.
- * Further research into its resistance mechanisms is essential for discovering novel fungicidal agents.
- * Understanding virulence and epidemiology is key to managing these infections effectively.
Related Concept Videos
Urinary Tract Infection IV: Nursing Management
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

